journal article Open Access Sep 10, 2024

The association between triglyceride-glucose index and its combination with systemic inflammation indicators and all-cause and cardiovascular mortality in the general US population: NHANES 1999–2018

View at Publisher Save 10.1186/s12944-024-02277-9
Topics

No keywords indexed for this article. Browse by subject →

References
54
[1]
McFarlane SI, Banerji M, Sowers JR. Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab. 2001;86(2):713–8. https://doi.org/10.1210/jcem.86.2.7202 10.1210/jcem.86.2.7202
[2]
Natali A, Ferrannini E. Hypertension, insulin resistance, and the metabolic syndrome. Endocrinol Metab Clin North Am. 2004;33(2):417–29. https://doi.org/10.1016/j.ecl.2004.03.007 10.1016/j.ecl.2004.03.007
[3]
Ferroni P, Basili S, Falco A, Davì G. Inflammation, insulin resistance, and obesity. Curr Atheroscler Rep. 2004;6(6):424–31. https://doi.org/10.1007/s11883-004-0082-x 10.1007/s11883-004-0082-x
[4]
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

D. R. Matthews, J. P. Hosker, A. S. Rudenski et al.

Diabetologia 1985 10.1007/bf00280883
[5]
The Product of Triglycerides and Glucose, a Simple Measure of Insulin Sensitivity. Comparison with the Euglycemic-Hyperinsulinemic Clamp

Fernando Guerrero-Romero, Luis E. Simental-Mendía, Manuel González-Ortiz et al.

The Journal of Clinical Endocrinology & Metabo... 2010 10.1210/jc.2010-0288
[6]
TyG index performs better than HOMA in a Brazilian population: A hyperglycemic clamp validated study

Ana Carolina Junqueira Vasques, Fernanda Satake Novaes, Maria da Saúde de Oliveira et al.

Diabetes Research and Clinical Practice 2011 10.1016/j.diabres.2011.05.030
[7]
Son DH, Lee HS, Lee YJ, Lee JH, Han JH. Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome. Nutr Metab Cardiovasc Dis. 2022;32(3):596–604. https://doi.org/10.1016/j.numecd.2021.11.017 10.1016/j.numecd.2021.11.017
[8]
Huang D, Ma R, Zhong X, Jiang Y, Lu J, Li Y, et al. Positive association between different triglyceride glucose index-related indicators and psoriasis: evidence from NHANES. Front Immunol. 2023;14:1325557. https://doi.org/10.3389/fimmu.2023.1325557 10.3389/fimmu.2023.1325557
[9]
Navarro-González D, Sánchez-Íñigo L, Pastrana-Delgado J, Fernández-Montero A, Martinez JA. Triglyceride-glucose index (TyG index) in comparison with fasting plasma glucose improved diabetes prediction in patients with normal fasting glucose: the vascular-metabolic CUN cohort. Prev Med. 2016;86:99–105. https://doi.org/10.1016/j.ypmed.2016.01.022 10.1016/j.ypmed.2016.01.022
[10]
Zhao M, Xiao M, Tan Q, Lu F. Triglyceride glucose index as a predictor of mortality in middle-aged and elderly patients with type 2 diabetes in the US. Sci Rep. 2023;13(1):16478. https://doi.org/10.1038/s41598-023-43512-0 10.1038/s41598-023-43512-0
[11]
Yao Y, Wang B, Geng T, Chen J, Chen W, Li L. The association between TyG and all-cause/non-cardiovascular mortality in general patients with type 2 diabetes mellitus is modified by age: results from the cohort study of NHANES 1999–2018. Cardiovasc Diabetol. 2024;23(1):43. https://doi.org/10.1186/s12933-024-02120-6 10.1186/s12933-024-02120-6
[12]
Liu Q, Zhang Y, Chen S, Xiang H, Ouyang J, Liu H, et al. Association of the triglyceride-glucose index with all-cause and cardiovascular mortality in patients with cardiometabolic syndrome: a national cohort study. Cardiovasc Diabetol. 2024;23(1):80. https://doi.org/10.1186/s12933-024-02152-y 10.1186/s12933-024-02152-y
[13]
Hou XZ, Lv YF, Li YS, Wu Q, Lv QY, Yang YT, et al. Association between different insulin resistance surrogates and all-cause mortality in patients with coronary heart disease and hypertension: NHANES longitudinal cohort study. Cardiovasc Diabetol. 2024;23(1):86. https://doi.org/10.1186/s12933-024-02173-7 10.1186/s12933-024-02173-7
[14]
Wei X, Min Y, Song G, Ye X, Liu L. Association between triglyceride-glucose related indices with the all-cause and cause-specific mortality among the population with metabolic syndrome. Cardiovasc Diabetol. 2024;23(1):134. https://doi.org/10.1186/s12933-024-02215-0 10.1186/s12933-024-02215-0
[15]
Ding L, Fu B, Zhang H, Dai C, Zhang A, Yu F, et al. The impact of triglyceride glucose-body mass index on all-cause and cardiovascular mortality in elderly patients with diabetes mellitus: evidence from NHANES 2007–2016. BMC Geriatr. 2024;24(1):356. https://doi.org/10.1186/s12877-024-04992-5 10.1186/s12877-024-04992-5
[16]
The Triglyceride-Glucose Index, an Insulin Resistance Marker, Was Non-linear Associated With All-Cause and Cardiovascular Mortality in the General Population

Xiao-cong Liu, Guo-dong He, Kenneth Lo et al.

Frontiers in Cardiovascular Medicine 2020 10.3389/fcvm.2020.628109
[17]
Chen J, Wu K, Lin Y, Huang M, Xie S. Association of triglyceride glucose index with all-cause and cardiovascular mortality in the general population. Cardiovasc Diabetol. 2023;22(1):320. https://doi.org/10.1186/s12933-023-02054-5 10.1186/s12933-023-02054-5
[18]
Liu X, Tan Z, Huang Y, Zhao H, Liu M, Yu P, et al. Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21(1):124. https://doi.org/10.1186/s12933-022-01546-0 10.1186/s12933-022-01546-0
[19]
Lopez-Jaramillo P, Gomez-Arbelaez D, Martinez-Bello D, Abat MEM, Alhabib KF, Avezum Á, et al. Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study. Lancet Healthy Longev. 2023;4(1):e23–33. https://doi.org/10.1016/s2666-7568(22)00247-1 10.1016/s2666-7568(22)00247-1
[20]
The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003–2018

Keke Dang, Xuanyang Wang, Jinxia Hu et al.

Cardiovascular Diabetology 2024 10.1186/s12933-023-02115-9
[21]
Alavi Tabatabaei G, Mohammadifard N, Rafiee H, Nouri F, Maghami Mehr A, Najafian J, et al. Association of the triglyceride glucose index with all-cause and cardiovascular mortality in a general population of Iranian adults. Cardiovasc Diabetol. 2024;23(1):66. https://doi.org/10.1186/s12933-024-02148-8 10.1186/s12933-024-02148-8
[22]
Yu Y, Wang J, Ding L, Huang H, Cheng S, Deng Y, et al. Sex differences in the nonlinear association of triglyceride glucose index with all-cause and cardiovascular mortality in the general population. Diabetol Metab Syndr. 2023;15(1):136. https://doi.org/10.1186/s13098-023-01117-7 10.1186/s13098-023-01117-7
[23]
Triglyceride Glucose (TyG) Index: A surrogate biomarker of insulin resistance

Vineetha K Ramdas Nayak, Praseeda Satheesh, Mohan T Shenoy et al.

Journal of the Pakistan Medical Association 2022 10.47391/jpma.22-63
[24]
Natali A, Toschi E, Baldeweg S, Ciociaro D, Favilla S, Saccà L, et al. Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes. Diabetes. 2006;55(4):1133–40. https://doi.org/10.2337/diabetes.55.04.06.db05-1076 10.2337/diabetes.55.04.06.db05-1076
[25]
Anuurad E, Tracy RP, Pearson TA, Kim K, Berglund L. Synergistic role of inflammation and insulin resistance as coronary artery disease risk factors in African Americans and Caucasians. Atherosclerosis. 2009;205(1):290–5. https://doi.org/10.1016/j.atherosclerosis.2008.11.028 10.1016/j.atherosclerosis.2008.11.028
[26]
Bennouar S, Bachir Cherif A, Aoudia Y, Abdi S. Additive interaction between insulin resistance, chronic low-grade inflammation and vitamin D deficiency on the risk of type 2 diabetes mellitus: a cohort study. J Am Nutr Assoc. 2024:1–11. https://doi.org/10.1080/27697061.2024.2352401 10.1080/27697061.2024.2352401
[27]
Ke J, Qiu F, Fan W, Wei S. Associations of complete blood cell count-derived inflammatory biomarkers with asthma and mortality in adults: a population-based study. Front Immunol. 2023;14:1205687. https://doi.org/10.3389/fimmu.2023.1205687 10.3389/fimmu.2023.1205687
[28]
Tudurachi BS, Anghel L, Tudurachi A, Sascău RA, Stătescu C. Assessment of inflammatory hematological ratios (NLR, PLR, MLR, LMR and monocyte/HDL-cholesterol ratio) in acute myocardial infarction and particularities in young patients. Int J Mol Sci. 2023;24(18). https://doi.org/10.3390/ijms241814378 10.3390/ijms241814378
[30]
The neutrophil-to-lymphocyte ratio is associated with mortality in the general population: The Rotterdam Study

Jesse Fest, T. Rikje Ruiter, Bas Groot Koerkamp et al.

European Journal of Epidemiology 2019 10.1007/s10654-018-0472-y
[31]
Song M, Graubard BI, Rabkin CS, Engels EA. Neutrophil-to-lymphocyte ratio and mortality in the United States general population. Sci Rep. 2021;11(1):464. https://doi.org/10.1038/s41598-020-79431-7 10.1038/s41598-020-79431-7
[32]
Monocyte-to-lymphocyte ratio predicts mortality and cardiovascular mortality in the general population

Yang Hua, Jin-Yu Sun, Yu-Xuan Lou et al.

International Journal of Cardiology 2023 10.1016/j.ijcard.2023.03.016
[33]
Mathur K, Kurbanova N, Qayyum R. Platelet-lymphocyte ratio (PLR) and all-cause mortality in general population: insights from national health and nutrition education survey. Platelets. 2019;30(8):1036–41. https://doi.org/10.1080/09537104.2019.1571188 10.1080/09537104.2019.1571188
[34]
Jin Z, Wu Q, Chen S, Gao J, Li X, Zhang X, et al. The associations of two novel inflammation indexes, SII and SIRI with the risks for cardiovascular diseases and all-cause mortality: a ten-year follow-up study in 85,154 individuals. J Inflamm Res. 2021;14:131–40. https://doi.org/10.2147/jir.S283835 10.2147/jir.s283835
[35]
Wang H, Nie H, Bu G, Tong X, Bai X. Systemic immune-inflammation index (SII) and the risk of all-cause, cardiovascular, and cardio-cerebrovascular mortality in the general population. Eur J Med Res. 2023;28(1):575. https://doi.org/10.1186/s40001-023-01529-1 10.1186/s40001-023-01529-1
[36]
Patel CJ, Pho N, McDuffie M, Easton-Marks J, Kothari C, Kohane IS, et al. A database of human exposomes and phenomes from the US national health and nutrition examination survey. Sci Data. 2016;3:160096. https://doi.org/10.1038/sdata.2016.96 10.1038/sdata.2016.96
[37]
Tian Y, Li D, Mu H, Wei S, Guo D. Positive correlation between snoring and dyslipidemia in adults: results from NHANES. Lipids Health Dis. 2023;22(1):73. https://doi.org/10.1186/s12944-023-01839-7 10.1186/s12944-023-01839-7
[38]
Chen Y, Lu C, Ju H, Zhou Q, Zhao X. Elevated AIP is associated with the prevalence of MAFLD in the US adults: evidence from NHANES 2017–2018. Front Endocrinol (Lausanne). 2024;15:1405828. https://doi.org/10.3389/fendo.2024.1405828 10.3389/fendo.2024.1405828
[39]
Smoking‐Attributable Periodontitis in the United States: Findings From NHANES III

Scott L. Tomar, Samira Asma

Journal of Periodontology 2000 10.1902/jop.2000.71.5.743
[40]
Rattan P, Penrice DD, Ahn JC, Ferrer A, Patnaik M, Shah VH, et al. Inverse association of telomere length with liver disease and mortality in the US population. Hepatol Commun. 2022;6(2):399–410. https://doi.org/10.1002/hep4.1803 10.1002/hep4.1803
[41]
Johnson CL, Paulose-Ram R, Ogden CL, Carroll MD, Kruszon-Moran D, Dohrmann SM, et al. National health and nutrition examination survey: analytic guidelines, 1999–2010. Vital Health Stat. 2013;2(161):1–24.
[46]
Chen Y, Chen S, Han Y, Xu Q, Zhao X. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are important indicators for predicting in-hospital death in elderly AMI patients. J Inflamm Res. 2023;16:2051–61. https://doi.org/10.2147/jir.S411086 10.2147/jir.s411086
[47]
Chen Y, Xie K, Han Y, Xu Q, Zhao X. An easy-to-use nomogram based on SII and SIRI to predict in-hospital mortality risk in elderly patients with acute myocardial infarction. J Inflamm Res. 2023;16:4061–71. https://doi.org/10.2147/jir.S427149 10.2147/jir.s427149
[48]
Pruc M, Peacock FW, Rafique Z, Swieczkowski D, Kurek K, Tomaszewska M, et al. The prognostic role of platelet-to-lymphocyte ratio in acute coronary syndromes: a systematic review and meta-analysis. J Clin Med. 2023;12(21). https://doi.org/10.3390/jcm12216903 10.3390/jcm12216903
[49]
Wang H, Li S, Yu J, Xu J, Xu Y. Role of leukocyte parameters in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with high thrombus burden. Front Cardiovasc Med. 2024;11:1397701. https://doi.org/10.3389/fcvm.2024.1397701 10.3389/fcvm.2024.1397701
[50]
Sjöholm A, Nyström T. Endothelial inflammation in insulin resistance. Lancet. 2005;365(9459):610–2. https://doi.org/10.1016/s0140-6736(05)17912-4 10.1016/s0140-6736(05)17912-4

Showing 50 of 54 references

Metrics
22
Citations
54
References
Details
Published
Sep 10, 2024
Vol/Issue
23(1)
License
View
Cite This Article
Yan Chen, Kailing Xie, Yuanyuan Han, et al. (2024). The association between triglyceride-glucose index and its combination with systemic inflammation indicators and all-cause and cardiovascular mortality in the general US population: NHANES 1999–2018. Lipids in Health and Disease, 23(1). https://doi.org/10.1186/s12944-024-02277-9